Summary.-A system is proposed by the UICC for assessing response to treatment of advanced breast cancers.
, and it was felt that agreement on a common system might readily be achieved. A preliminary document describing such a system was prepared, and was then circulated to many workers in the field for comment, after which it was revised accordingly. The final document is now presented. It is hoped that this system will be widely adopted and that it may eventually be used as a model for the assessment of therapy of other tumours. It has been accepted by the British Breast Group and replaces its previously published assessment method (British Breast Group, 1974 11. Duration of response In a patient who has an objective regression, this is to be dated from the start of therapy until either new lesions appear or any one existing lesion increases by 25% or more above its smallest size recorded.
It is essential to categorize a patient as having a regression at a stated time. It is also essential that all baseline studies should have been repeated at this time.
Survival
Survival, dated from time of commencement of treatment to death, should be recorded.
Extra-mural review
It is recommended that the records of all patients under study be assessed by extra-mural reviewers.
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